| |
|
French Approval of Botox Injections
— IRVINE, Calif. - Allergan Inc. said on Tuesday it had received approval by the French regulators for the use of its Botox wrinkle-fighting product in the treatment of frown lines between the eyebrows.
Botox will be marketed in France under the name Vistabel after the company said it received a nod from the Agence Francaise de Securite Sanitaire des Produits de Sante.
France will act as the Reference Member State in the mutual recognition process for this indication within the European Union, Allergan said.
The treatment will be used for Glabellar lines, which are formed by excessive contractions of two of the major muscles in the forehead, the corrugator and procerus.
This approved indication is now licensed for use in 19 countries including the United States, Canada, Australia, New Zealand and Switzerland, Allergan said.
The company is fighting a lawsuit filed in Los Angeles, California, alleging that Botox causes a chronic medical condition. The company said any side effects were temporary.
|
|
This article is not intended to be a source of medical
information and certainly does not take the place of qualified medical advice
or consultation. It is provided merely as a source of information submitted
by users of this site. If you are considering any procedure you should consult
a doctor first.
For more information on botox, botox
injections, botox information, botox headaches, botox migraine, botox party, botox price, botox cost, botox and side effects, botox before and after, cosmetic surgery, antiaging, wrinkle, botox injection, allergen,
wrinkle cures, allergen, wrinkle treatment, facial wrinkle, botox treatment,
botox party, botox side effects, botox manufacturer, botox cosmetic, botox shots, or allergen please consult a doctor. |
|
| |
|
|
|
